News | August 12, 2023
Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The medical device sector is considered as one of the sunrise sectors in the country
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
